NDC 67979-500

Vantas

Histrelin Acetate

Vantas is a Subcutaneous Implant in the Human Prescription Drug category. It is labeled and distributed by Endo Pharmaceuticals Inc.. The primary component is Histrelin Acetate.

• Product ID: 67979-500_15a4c4f5-8f1f-45b4-88bf-d4cda5ed9839
• NDC: 67979-500
• Product Type: Human Prescription Drug
• Proprietary Name: Vantas
• Generic Name: Histrelin Acetate
• Dosage Form: Implant
• Route of Administration: SUBCUTANEOUS
• Marketing Start Date: 2004-11-01
• Marketing Category: NDA / NDA
• Application Number: NDA021732
• Labeler Name: Endo Pharmaceuticals Inc.
• Substance Name: HISTRELIN ACETATE
• Active Ingredient Strength: 50 mg/1
• Pharm Classes: Gonadotropin Releasing Hormone Receptor Agonist [EPC],Gonadotropin Releasing Hormone Receptor Agonists [MoA]
• NDC Exclude Flag: N
• Listing Certified Through: 2022-12-31

Packaging

NDC 67979-500-01

1 VIAL, GLASS in 1 CARTON (67979-500-01) > 1 IMPLANT in 1 VIAL, GLASS

• Marketing Start Date: 2004-11-01
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 67979-500-01 [67979050001]

Vantas IMPLANT

• Marketing Category: NDA
• Application Number: NDA021732
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: EA
• Marketing Start Date: 2004-11-01

Drug Details

Active Ingredients

Ingredient	Strength
HISTRELIN ACETATE	50 mg/1

OpenFDA Data

• SPL SET ID: 78b88748-8318-11dc-8314-0800200c9a66
• Manufacturer:
  • Endo Pharmaceuticals Solutions Inc.
• UNII:
  • QMG7HLD1ZE
• RxNorm Concept Unique ID - RxCUI:
  • 1740433
  • 1294626

Pharmacological Class

• Gonadotropin Releasing Hormone Receptor Agonist [EPC]
• Gonadotropin Releasing Hormone Receptor Agonists [MoA]

NDC Crossover Matching brand name "Vantas" or generic name "Histrelin Acetate"

NDC	Brand Name	Generic Name
67979-500	Vantas	histrelin acetate
67979-002	SUPPRELIN	histrelin acetate